Azacitidine
About
Therapy type: Chemotherapy
Therapy strategy: Hypomethylating agent chemotherapy
Mappings
NCI Thesaurus: Azacitidine (ncit:C288)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | IDH1 p.R132C | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132G | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132H | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132L | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132S | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132C | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132G | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132H | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132L | Acute Myeloid Leukemia | Azacitidine, Ivosidenib | |
| Sensitivity (+) | IDH1 p.R132S | Acute Myeloid Leukemia | Azacitidine, Ivosidenib |